Health
Phase 1 trial results of gorilla adenovirus vaccine for COVID-19 – News-Medical.Net
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained…
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help speed up vaccine development.
Low Seroprevalence for Simian Adenoviruses
Simian adenoviruses are isolated from non-human primates like the chimpanzee and gorilla and do not infect humans. Their prevalence is, therefore, low or non-existent among humans. They have been used to…
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News21 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation